Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    >> Share

  2. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    >> Share

  3. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    >> Share

  4. DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
    beta2-glycoprotein I promotes the clearance of circulating mitochondria.
    PLoS One. 2024;19:e0293304.
    >> Share

  5. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    >> Share

  6. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    >> Share

  7. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    >> Share

  8. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    >> Share

  9. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    >> Share

  10. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    >> Share

  11. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    >> Share

  12. LIU X, Xue J, Li T, Wu Q, et al
    Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    PLoS One. 2024;19:e0298269.
    >> Share

  13. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    >> Share

  14. TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
    Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
    PLoS One. 2024;19:e0297625.
    >> Share

  15. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    >> Share

  16. LIU P, Luo J, Zhao L, Fu Q, et al
    Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297861.
    >> Share

  17. FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
    Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
    PLoS One. 2024;19:e0298796.
    >> Share

  18. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

  19. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    >> Share

  20. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    >> Share

  21. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    >> Share

  22. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    >> Share

  23. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    >> Share

  24. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    >> Share

  25. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    >> Share

  26. JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
    COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
    PLoS One. 2024;19:e0298571.
    >> Share

  27. MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
    Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296998.
    >> Share

    January 2023
  28. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    >> Share

  29. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    >> Share

  30. DE SONNAVILLE WFC, Steenks MH, Zuithoff NPA, Wulffraat NM, et al
    Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children.
    PLoS One. 2023;18:e0280763.
    >> Share

  31. KANSUTTIVIWAT C, Niprapan P, Tantiworawit A, Norasetthada L, et al
    Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
    PLoS One. 2023;18:e0279450.
    >> Share

  32. VAN TIENHOVEN R, Vu AN, Kaddis JS, Roep BO, et al
    Low risk for diabetic complications in type 1 diabetes patients carrying a protective insulin gene variant.
    PLoS One. 2023;18:e0280872.
    >> Share

  33. HARARI G, Gurevich M, Dolev M, Zilkha Falb R, et al
    Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study.
    PLoS One. 2023;18:e0280515.
    >> Share

  34. GON Y, Kandou T, Tsuruyama T, Iwasaki T, et al
    Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.
    PLoS One. 2023;18:e0279389.
    >> Share

  35. GRANJA DOMINGUEZ A, Romero Sevilla R, Aleman A, Duran C, et al
    Study for the validation of the FeetMe(R) integrated sensor insole system compared to GAITRite(R) system to assess gait characteristics in patients with multiple sclerosis.
    PLoS One. 2023;18:e0272596.
    >> Share

  36. VICH-PEREZ P, Abanades-Herranz JC, Mora-Navarro G, Carrasco-Sayalero AM, et al
    Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study.
    PLoS One. 2023;18:e0281657.
    >> Share

  37. CABANILLAS-LAZO M, Cruzalegui-Bazan C, Pascual-Guevara M, Quispe-Vicuna C, et al
    Clinical and imagenologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: A systematic review with meta-analysis.
    PLoS One. 2023;18:e0281064.
    >> Share

  38. SOFUE T, Oguchi H, Yazawa M, Tsujita M, et al
    Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
    PLoS One. 2023;18:e0281945.
    >> Share

  39. BARAK-CORREN Y, Castro VM, Javitt S, Nock MK, et al
    Improving risk prediction for target subpopulations: Predicting suicidal behaviors among multiple sclerosis patients.
    PLoS One. 2023;18:e0277483.
    >> Share

  40. SWERDEL JN, Ramcharran D, Hardin J
    Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.
    PLoS One. 2023;18:e0281929.
    >> Share

  41. ALAZWARI A, Johnstone A, Tafakori L, Abdollahian M, et al
    Predicting the development of T1D and identifying its Key Performance Indicators in children; a case-control study in Saudi Arabia.
    PLoS One. 2023;18:e0282426.
    >> Share

  42. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    >> Share

  43. ERSOY T, Hocaoglu E
    A 3-DoF robotic platform for the rehabilitation and assessment of reaction time and balance skills of MS patients.
    PLoS One. 2023;18:e0280505.
    >> Share

  44. RAGY O, Rautemaa V, Smith A, Brenchley P, et al
    Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
    PLoS One. 2023;18:e0281726.
    >> Share

  45. SOKRATOUS D, Charalambous CC, Papanicolaou EZ, Michailidou K, et al
    Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
    PLoS One. 2023;18:e0272114.
    >> Share

  46. MISAKI T, Naka S, Suzuki H, Lee M, et al
    cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
    PLoS One. 2023;18:e0282367.
    >> Share

  47. CHOI SJ, Ahn SM, Oh JS, Hong S, et al
    Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
    PLoS One. 2023;18:e0282852.
    >> Share

  48. FEHMI J, Davies AJ, Antonelou M, Keddie S, et al
    Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
    PLoS One. 2023;18:e0281156.
    >> Share

  49. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app.
    PLoS One. 2023;18:e0283148.
    >> Share

  50. LIPKA S, Ostendorf L, Schneider U, Hiepe F, et al
    Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis.
    PLoS One. 2023;18:e0282919.
    >> Share

  51. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    >> Share

  52. LAICHINGER K, Bombach P, Dunschede J, Ruschil C, et al
    No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.
    PLoS One. 2023;18:e0283476.
    >> Share

  53. LEDEGANCK KJ, Van Eyck A, Wouters K, Vermeiren E, et al
    Urinary epidermal growth factor reflects vascular health in boys with either obesity or type 1 diabetes. A role for renin, or beyond?
    PLoS One. 2023;18:e0283716.
    >> Share

  54. ZAFEIRI L, Akerfeldt T, Tolf A, Carlson K, et al
    Anti-Mullerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    PLoS One. 2023;18:e0284288.
    >> Share

  55. WANG Y, Hurley A, De Giorgi M, Tanner MR, et al
    Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
    PLoS One. 2023;18:e0283996.
    >> Share

  56. NOPPARAT J, Khuituan P, Peerakietkhajorn S, Teanpaisan R, et al
    Probiotics of Lacticaseibacillus paracasei SD1 and Lacticaseibacillus rhamnosus SD11 attenuate inflammation and beta-cell death in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2023;18:e0284303.
    >> Share

  57. HANGANU AR, Constantin A, Moise ES, Niculae CM, et al
    Peripheral nervous system involvement associated with COVID-19. A systematic review of literature.
    PLoS One. 2023;18:e0283827.
    >> Share

  58. BENINI S, Pellegrini E, Descovich C, Lugaresi A, et al
    Burden and resources in caregivers of people with multiple sclerosis: A qualitative study.
    PLoS One. 2023;18:e0265297.
    >> Share

  59. MARTINS ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, et al
    In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy.
    PLoS One. 2023;18:e0284789.
    >> Share

  60. CRAWFORD MP, Borcherding N, Karandikar NJ
    IL-17 cytokines preferentially act on naive CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes.
    PLoS One. 2023;18:e0285166.
    >> Share

  61. HAMILTON P, Blaikie K, Roberts SA, Gittins M, et al
    Membranous nephropathy in the UK Biobank.
    PLoS One. 2023;18:e0281795.
    >> Share

  62. LEE SH, Lee S, Lee J, Lee JK, et al
    Effective encoder-decoder neural network for segmentation of orbital tissue in computed tomography images of Graves' orbitopathy patients.
    PLoS One. 2023;18:e0285488.
    >> Share

  63. SU K, Jia Z, Wu Y, Sun Y, et al
    A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.
    PLoS One. 2023;18:e0285915.
    >> Share

  64. AHMAD POUZI NA, Shaharir SS, Mohd Tamil A, Mustafar R, et al
    Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    PLoS One. 2023;18:e0285461.
    >> Share

  65. COBB J, Soliman SSM, Retuerto M, Quijano JC, et al
    Changes in the gut microbiota of NOD mice in response to an oral Salmonella-based vaccine against type 1 diabetes.
    PLoS One. 2023;18:e0285905.
    >> Share

  66. HORVATH M, Herold Z, Kustel M, Tamas L, et al
    Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus.
    PLoS One. 2023;18:e0285740.
    >> Share

  67. MACHADO-ALBA JE, Machado-Duque ME, Gaviria-Mendoza A, Duarte-Rey C, et al
    Clinical characterization of a cohort of patients treated for systemic lupus erythematosus in Colombia: A retrospective study.
    PLoS One. 2023;18:e0285889.
    >> Share

  68. STAHL D, Friberg E
    Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.
    PLoS One. 2023;18:e0286010.
    >> Share

  69. MISTRY S, Gouripeddi R, Reno CM, Abdelrahman S, et al
    Detecting hypoglycemia-induced electrocardiogram changes in a rodent model of type 1 diabetes using shape-based clustering.
    PLoS One. 2023;18:e0284622.
    >> Share

  70. ZAK R, Navasardyan L, Hunak J, Martinu J, et al
    PTPN22 intron polymorphism rs1310182 (c.2054-852T>C) is associated with type 1 diabetes mellitus in patients of Armenian descent.
    PLoS One. 2023;18:e0286743.
    >> Share

  71. EVEREST E, Uygunoglu U, Tutuncu M, Bulbul A, et al
    Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
    PLoS One. 2023;18:e0287463.
    >> Share

  72. STEYN LV, Drew D, Vlachos D, Huey B, et al
    Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus.
    PLoS One. 2023;18:e0278794.
    >> Share

  73. MEDEIROS MCS, Souza KSC, Galdino OA, Cobucci RN, et al
    Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol.
    PLoS One. 2023;18:e0287753.
    >> Share

  74. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    >> Share

  75. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    PLoS One. 2023;18:e0285599.
    >> Share

  76. TURTON JL, Brinkworth GD, Parker HM, Lim D, et al
    Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial.
    PLoS One. 2023;18:e0288440.
    >> Share

  77. NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
    Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
    PLoS One. 2023;18:e0288319.
    >> Share

  78. VIATCHENKO-KARPINSKI V, Kong L, Weng HR
    Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice.
    PLoS One. 2023;18:e0288356.
    >> Share

  79. VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
    Evaluation of multiple sclerosis severity using a new OCT tool.
    PLoS One. 2023;18:e0288581.
    >> Share

  80. FRAGKIADAKI E, Cotterill N, Rice C, Smith JA, et al
    Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol.
    PLoS One. 2023;18:e0288295.
    >> Share

  81. WANG TY, Chang FP, Yang AH, Ka SM, et al
    Key pathological features characterize minimal change disease-like IgA nephropathy.
    PLoS One. 2023;18:e0288384.
    >> Share

  82. GOUGH A, Sitch A, Ferris E, Marshall T, et al
    Within-subject variation of HbA1c: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0289085.
    >> Share

  83. MACHADO A, Azad A, Pettersson E, Hillert J, et al
    Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references.
    PLoS One. 2023;18:e0288998.
    >> Share

  84. MEIJBOOM R, York EN, Kampaite A, Harris MA, et al
    Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    PLoS One. 2023;18:e0288967.
    >> Share

  85. HERNANDEZ M, Ramon-Julvez U, Vilades E, Cordon B, et al
    Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography.
    PLoS One. 2023;18:e0289495.
    >> Share

  86. RAZIA R, Majeed F, Amin R, Mukhtar S, et al
    Predictive value of alpha-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
    PLoS One. 2023;18:e0285022.
    >> Share

  87. DING J, Li C, Shu K, Chen W, et al
    Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.
    PLoS One. 2023;18:e0289960.
    >> Share

  88. HARRIS VK, Wollowitz J, Greenwald J, Carlson AL, et al
    Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis.
    PLoS One. 2023;18:e0290069.
    >> Share

  89. DEFRES S, Tharmaratnam K, Michael BD, Ellul M, et al
    Clinical predictors of encephalitis in UK adults-A multi-centre prospective observational cohort study.
    PLoS One. 2023;18:e0282645.
    >> Share

  90. ULLAH S, Zheng Z, Rahman W, Ullah F, et al
    A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids.
    PLoS One. 2023;18:e0290576.
    >> Share

  91. GOOCH AM, Chowdhury SS, Zhang PM, Hu ZM, et al
    Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.
    PLoS One. 2023;18:e0290460.
    >> Share

  92. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
    Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
    PLoS One. 2023;18:e0291063.
    >> Share

  93. LIN DY, Andreotti AH
    Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
    PLoS One. 2023;18:e0290872.
    >> Share

  94. MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
    Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
    PLoS One. 2023;18:e0289258.
    >> Share

  95. HOWLAND S, Huber J, Aicken C
    Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
    PLoS One. 2023;18:e0285300.
    >> Share

  96. SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
    Serum metabolomics of treatment response in myasthenia gravis.
    PLoS One. 2023;18:e0287654.
    >> Share

  97. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
    Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
    PLoS One. 2023;18:e0292233.
    >> Share

  98. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    >> Share

  99. PARK SS, Mai M, Ploszaj M, Cai H, et al
    Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
    PLoS One. 2023;18:e0291948.
    >> Share

  100. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    >> Share

  101. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
    The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
    PLoS One. 2023;18:e0293908.
    >> Share

  102. ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
    Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
    PLoS One. 2023;18:e0294432.
    >> Share

  103. CHENG CW, Fang WF, Lin JD
    Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
    PLoS One. 2023;18:e0289345.
    >> Share

  104. SUZUKI K, Iwata D, Namba K, Hase K, et al
    Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
    PLoS One. 2023;18:e0294745.
    >> Share

  105. WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
    The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295011.
    >> Share

  106. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    >> Share

  107. HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
    Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
    PLoS One. 2023;18:e0294982.
    >> Share

  108. TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
    Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
    PLoS One. 2023;18:e0295284.
    >> Share

  109. LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
    Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
    PLoS One. 2023;18:e0293268.
    >> Share

  110. FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
    Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
    PLoS One. 2023;18:e0295026.
    >> Share

  111. ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
    Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
    PLoS One. 2023;18:e0295549.
    >> Share

  112. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
    Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
    PLoS One. 2023;18:e0288366.
    >> Share

    January 2022
  113. YU F, Zhou X, Jin X, Zhao S, et al
    Rational construction of controllable autoimmune diabetes model depicting clinical features.
    PLoS One. 2022;17:e0260100.
    >> Share

  114. OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
    Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
    PLoS One. 2022;17:e0261769.
    >> Share

  115. ARIF B, Arif Z, Ahmad J, Perveen K, et al
    Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
    PLoS One. 2022;17:e0262233.
    >> Share

  116. KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
    Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
    PLoS One. 2022;17:e0262677.
    >> Share

  117. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    >> Share

  118. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    >> Share

  119. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    >> Share

  120. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    >> Share

  121. PETROVA T, Bennett K, Nanda S, Strickson S, et al
    Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
    PLoS One. 2022;17:e0263151.
    >> Share

  122. LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022;17:e0263536.
    >> Share

  123. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    >> Share

  124. ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
    Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
    PLoS One. 2022;17:e0264118.
    >> Share

  125. BEDI S, Richardson TM, Jia B, Saab H, et al
    Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
    PLoS One. 2022;17:e0261103.
    >> Share

  126. TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
    Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0263774.
    >> Share

  127. QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
    Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    PLoS One. 2022;17:e0263511.
    >> Share

  128. LI JY, Sun XH, Shen DC, Yang XZ, et al
    Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
    PLoS One. 2022;17:e0266529.
    >> Share

  129. MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
    Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
    PLoS One. 2022;17:e0264626.
    >> Share

  130. KONG X, Diao S, Xu H, Sun J, et al
    Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
    PLoS One. 2022;17:e0266265.
    >> Share

  131. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    >> Share

  132. QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
    The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
    PLoS One. 2022;17:e0266809.
    >> Share

  133. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    >> Share

  134. CHEN X, Zhang Y, Luo Z, Wu Y, et al
    Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0264705.
    >> Share

  135. TANA MM, Klepper A, Lyden A, Pisco AO, et al
    Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    PLoS One. 2022;17:e0264307.
    >> Share

  136. NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
    Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    PLoS One. 2022;17:e0263778.
    >> Share

  137. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    >> Share

  138. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    >> Share

  139. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    >> Share

  140. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    >> Share

  141. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    >> Share

  142. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    >> Share

  143. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    >> Share

  144. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    >> Share

  145. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    >> Share

  146. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    >> Share

  147. RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
    The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
    PLoS One. 2022;17:e0267913.
    >> Share

  148. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    >> Share

  149. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    >> Share

  150. HIERL KV, Krause M, Kruber D, Sterker I, et al
    3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
    PLoS One. 2022;17:e0265324.
    >> Share

  151. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    >> Share

  152. IIDA M, Ohtomo S, Wada NA, Ueda O, et al
    TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
    PLoS One. 2022;17:e0265081.
    >> Share

  153. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    >> Share

  154. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    >> Share

  155. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    >> Share

  156. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    >> Share

  157. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    >> Share

  158. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    >> Share

  159. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    >> Share

  160. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    >> Share

  161. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    >> Share

  162. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    >> Share

  163. MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
    Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
    PLoS One. 2022;17:e0270142.
    >> Share

  164. HUANG Y, Wang WK, Zheng XM, Yang L, et al
    Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
    PLoS One. 2022;17:e0269621.
    >> Share

  165. PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
    IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
    PLoS One. 2022;17:e0270607.
    >> Share

  166. ALBURNO H, Mercken L, de Vries H, Al Mohannadi D, et al
    Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study.
    PLoS One. 2022;17:e0270984.
    >> Share

  167. RASKIN E, Achiron A, Zloto O, Neuman R, et al
    Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
    PLoS One. 2022;17:e0264918.
    >> Share

  168. HAYASHI K, Sada KE, Asano Y, Katayama Y, et al
    Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
    PLoS One. 2022;17:e0270569.
    >> Share

  169. KRAUSE A, Lee K, Konig D, Faist M, et al
    Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
    PLoS One. 2022;17:e0270698.
    >> Share

  170. AFYOUNI H, Haris B, Syed N, Ahmed I, et al
    Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar.
    PLoS One. 2022;17:e0271182.
    >> Share

  171. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study.
    PLoS One. 2022;17:e0271055.
    >> Share

  172. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    >> Share

  173. SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
    Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
    PLoS One. 2022;17:e0269466.
    >> Share

  174. BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
    A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
    PLoS One. 2022;17:e0269925.
    >> Share

  175. LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
    Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
    PLoS One. 2022;17:e0270890.
    >> Share

  176. VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
    Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0272156.
    >> Share

  177. UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
    Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
    PLoS One. 2022;17:e0272133.
    >> Share

  178. TU H, Li N, Liu W, Fan Z, et al
    Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0269371.
    >> Share

  179. PAPADIMITRIOU E, Boutzios G, Mathioudakis AG, Vlahos NF, et al
    Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0260759.
    >> Share

  180. QIU LNY, Cai SV, Chan D, Hess RS, et al
    Seasonality and geography of diabetes mellitus in United States of America dogs.
    PLoS One. 2022;17:e0272297.
    >> Share

  181. MAHMOUD RH, Fouad NA, Hefzy EM, Shaker OG, et al
    The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.
    PLoS One. 2022;17:e0268176.
    >> Share

  182. MORRISON AE, Chong K, Senior PA, Lam A, et al
    A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    PLoS One. 2022;17:e0271096.
    >> Share

  183. HOHN A, McGurnaghan SJ, Caparrotta TM, Jeyam A, et al
    Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018.
    PLoS One. 2022;17:e0271110.
    >> Share

  184. CRABTREE E, Uribe K, Smith SM, Roberts D, et al
    Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
    PLoS One. 2022;17:e0270972.
    >> Share

  185. LI Y, Yu X, Zhang W, Lv J, et al
    Epidemiological characteristics and pathological changes of primary glomerular diseases.
    PLoS One. 2022;17:e0272237.
    >> Share

  186. CHOI YJ, Kim C, Choi EW, Lee SH, et al
    MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    PLoS One. 2022;17:e0270416.
    >> Share

  187. SEKIGUCHI K, Ishizuchi K, Takizawa T, Motegi H, et al
    Anemia in female patients with myasthenia gravis.
    PLoS One. 2022;17:e0273720.
    >> Share

  188. STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
    The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
    PLoS One. 2022;17:e0268421.
    >> Share

  189. VIROONLUECHA P, Egea-Lopez E, Santa J
    Evaluation of blood glucose level control in type 1 diabetic patients using deep reinforcement learning.
    PLoS One. 2022;17:e0274608.
    >> Share

  190. TAKASHI Y, Maeda Y, Toyokawa K, Oda N, et al
    Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes.
    PLoS One. 2022;17:e0274182.
    >> Share

  191. JOH K, Nakazato T, Hashiguchi A, Shimizu A, et al
    Structural modeling for Oxford histological classifications of immunoglobulin A nephropathy.
    PLoS One. 2022;17:e0268731.
    >> Share

  192. LAROCQUE JC, Gardy S, Sammut M, McBey DP, et al
    Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0273701.
    >> Share

  193. YOSHIKAWA H, Adachi Y, Nakamura Y, Kuriyama N, et al
    Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018.
    PLoS One. 2022;17:e0274161.
    >> Share

  194. CARREIRA M, Ruiz de Adana MS, Pinzon JL, Anarte-Ortiz MT, et al
    Internet-based Cognitive-behavioral therapy (CBT) for depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study): A randomized controlled trial protocol.
    PLoS One. 2022;17:e0274551.
    >> Share

  195. KUENDIG S, Kool J, Polhemus A, Schallert W, et al
    Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability.
    PLoS One. 2022;17:e0274348.
    >> Share

  196. SMAOUI MR, Lafi A
    Leeno: Type 1 diabetes management training environment using smart algorithms.
    PLoS One. 2022;17:e0274534.
    >> Share

  197. NING L, Wang B
    Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0274565.
    >> Share

  198. ABUAF AF, Bunting SR, Klein S, Carroll T, et al
    Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
    PLoS One. 2022;17:e0274778.
    >> Share

  199. ALMAZROUEI R, Sharma C, Afandi B, Aldahmani KM, et al
    Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
    PLoS One. 2022;17:e0264545.
    >> Share

  200. DING MY, Li B, Yang M, Zhai WS, et al
    Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis.
    PLoS One. 2022;17:e0275122.
    >> Share

  201. YAMAGUCHI M, Ito M, Sugiyama H, Iwagaitsu S, et al
    Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.
    PLoS One. 2022;17:e0274483.
    >> Share

  202. GUIMARAES JAR, Furtado SDC, Lucas ACDS, Mori B, et al
    Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
    PLoS One. 2022;17:e0275016.
    >> Share

  203. JENSEN MH, Cichosz SL, Gustenhoff P, Nikontovic A, et al
    Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    PLoS One. 2022;17:e0274626.
    >> Share

  204. STORRAR J, Gill-Taylor T, Chinnadurai R, Chrysochou C, et al
    A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
    PLoS One. 2022;17:e0276053.
    >> Share

  205. MASIS L, Kanya L, Kiogora J, Kiapi L, et al
    Estimating treatment costs for uncomplicated diabetes at a hospital serving refugees in Kenya.
    PLoS One. 2022;17:e0276702.
    >> Share

  206. SELVARAJ MS, Paruchuri K, Haidermota S, Bernardo R, et al
    Genome-wide discovery for diabetes-dependent triglycerides-associated loci.
    PLoS One. 2022;17:e0275934.
    >> Share

  207. GRANLUND L, Hedin A, Korsgren O, Skog O, et al
    Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
    PLoS One. 2022;17:e0276942.
    >> Share

  208. AMATYA M, Pant AD
    Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
    PLoS One. 2022;17:e0276172.
    >> Share

  209. DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
    Low serum uromodulin levels and their association with lupus flares.
    PLoS One. 2022;17:e0276481.
    >> Share

  210. CHEN W, Yu Y, Liu Y, Song C, et al
    Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats.
    PLoS One. 2022;17:e0277061.
    >> Share

  211. RICCI S, Perugia F, Piccini B, Lodi L, et al
    DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy.
    PLoS One. 2022;17:e0276896.
    >> Share

  212. BAYARMUNKH O, Ganbold C, Das S, Davaatseren U, et al
    Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    PLoS One. 2022;17:e0277055.
    >> Share

  213. BOYARCHUK O, Dobrovolska L, Svystunovych H
    Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine.
    PLoS One. 2022;17:e0277273.
    >> Share

  214. YANG B, Parker RB, Meibohm B, Temrikar ZH, et al
    Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis.
    PLoS One. 2022;17:e0278111.
    >> Share

  215. VALORI M, Lehikoinen J, Jansson L, Clancy J, et al
    High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls.
    PLoS One. 2022;17:e0278245.
    >> Share

  216. CROMER SJ, Chen V, Han C, Marshall W, et al
    Algorithmic identification of atypical diabetes in electronic health record (EHR) systems.
    PLoS One. 2022;17:e0278759.
    >> Share

  217. ALAZMI A, Viktor S, Erjavec M
    Exploring the determinants of mental health, wellbeing, and lifestyle in 8-11 year old children with type 1 diabetes and their healthy counterparts in Kuwait.
    PLoS One. 2022;17:e0272948.
    >> Share

  218. CLARKSON TC, Iguchi N, Xie AX, Malykhina AP, et al
    Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus.
    PLoS One. 2022;17:e0278918.
    >> Share

  219. BROOME CM, Hooda N, Su J, Jiang X, et al
    Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
    PLoS One. 2022;17:e0276617.
    >> Share

  220. AL-KAFAJI G, Alwehaidah MS, Alsabbagh MM, Alharbi MA, et al
    Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis.
    PLoS One. 2022;17:e0279237.
    >> Share

  221. PARK HY, Chae MK, Ko J, Kikkawa DO, et al
    Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
    PLoS One. 2022;17:e0279060.
    >> Share

  222. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2022;17:e0270875.
    >> Share

  223. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
    PLoS One. 2022;17:e0279132.
    >> Share

  224. LANDRUM KR, Pence BW, Gaynes BN, Dussault JM, et al
    The cross-sectional association of stressful life events with depression severity among patients with hypertension and diabetes in Malawi.
    PLoS One. 2022;17:e0279619.
    >> Share

    January 2021
  225. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    >> Share

  226. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    >> Share

  227. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    >> Share

  228. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    >> Share

  229. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    >> Share

  230. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    >> Share

  231. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    >> Share

  232. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    >> Share

  233. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    >> Share

  234. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    >> Share

  235. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    >> Share

  236. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    >> Share

  237. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    >> Share

  238. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    >> Share

  239. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    >> Share

  240. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    >> Share

  241. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    >> Share

  242. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    >> Share

  243. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    >> Share

  244. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    >> Share

  245. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    >> Share

  246. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    >> Share

  247. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    >> Share

  248. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    >> Share

  249. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    >> Share

  250. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    >> Share

  251. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    >> Share

  252. LUU T, Cheung JF, Baccon J, Waldner H, et al
    Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2021;16:e0250340.
    >> Share

  253. SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
    Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
    PLoS One. 2021;16:e0250215.
    >> Share

  254. LIU GY, Wu Y, Kong FY, Ma S, et al
    BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
    PLoS One. 2021;16:e0243014.
    >> Share

  255. SATITPITAKUL V, Rattanaphong T, Pruksakorn V
    Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
    PLoS One. 2021;16:e0250617.
    >> Share

  256. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    >> Share

  257. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    >> Share

  258. ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
    Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    PLoS One. 2021;16:e0248280.
    >> Share

  259. SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
    B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
    PLoS One. 2021;16:e0248056.
    >> Share

  260. SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
    Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    PLoS One. 2021;16:e0248845.
    >> Share

  261. CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
    Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
    PLoS One. 2021;16:e0247901.
    >> Share

  262. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    >> Share

  263. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    >> Share

  264. SATO H, Ichikawa D, Okada E, Suzuki T, et al
    Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    PLoS One. 2021;16:e0251294.
    >> Share

  265. LU Z, Liu W, Gao H, Chen W, et al
    Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251131.
    >> Share

  266. FATOYE F, Gebrye T, Svenson LW
    Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    PLoS One. 2021;16:e0251409.
    >> Share

  267. LIAO K, Chen K, Brett S, Gehman A, et al
    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
    PLoS One. 2021;16:e0249049.
    >> Share

  268. CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
    Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
    PLoS One. 2021;16:e0252236.
    >> Share

  269. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    >> Share

  270. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    >> Share

  271. STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
    PLoS One. 2021;16:e0254859.
    >> Share

  272. MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
    Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    PLoS One. 2021;16:e0255317.
    >> Share

  273. NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
    Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0251709.
    >> Share

  274. HOFFMAN WH, Whelan SA, Lee N
    Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
    PLoS One. 2021;16:e0254116.
    >> Share

  275. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    >> Share

  276. SWANN JW, Tayler S, Hall H, Sparrow R, et al
    Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    PLoS One. 2021;16:e0257700.
    >> Share

  277. MCCALL JL, Blair HC, Blethen KE, Hall C, et al
    Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
    PLoS One. 2021;16:e0249442.
    >> Share

  278. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    >> Share

  279. KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
    Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    PLoS One. 2021;16:e0254718.
    >> Share

  280. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
    PLoS One. 2021;16:e0254226.
    >> Share

  281. JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
    Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
    PLoS One. 2021;16:e0253844.
    >> Share

  282. BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
    Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    PLoS One. 2021;16:e0254079.
    >> Share

  283. NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    PLoS One. 2021;16:e0253793.
    >> Share

  284. FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
    Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
    PLoS One. 2021;16:e0253389.
    >> Share

  285. VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
    Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
    PLoS One. 2021;16:e0253125.
    >> Share

  286. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    >> Share

  287. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    >> Share

  288. WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
    Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
    PLoS One. 2021;16:e0252588.
    >> Share

  289. WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
    Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
    PLoS One. 2021;16:e0252638.
    >> Share

  290. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    >> Share

  291. ROZYCKA J
    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    >> Share

  292. PARIKH RV, Tan TC, Fan D, Law D, et al
    Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    PLoS One. 2021;16:e0257674.
    >> Share

  293. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    >> Share

  294. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    >> Share

  295. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    >> Share

  296. JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
    Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    PLoS One. 2021;16:e0255344.
    >> Share

  297. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    >> Share

  298. SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
    PLoS One. 2021;16:e0254634.
    >> Share

  299. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    >> Share

  300. TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
    Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    PLoS One. 2021;16:e0258090.
    >> Share

  301. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    >> Share

  302. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    >> Share

  303. KIM SS, Hudgins AD, Yang J, Zhu Y, et al
    A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    PLoS One. 2021;16:e0257265.
    >> Share

  304. OSAKI T, Souri M, Ichinose A
    Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
    PLoS One. 2021;16:e0257322.
    >> Share

  305. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    >> Share

  306. NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
    PLoS One. 2021;16:e0257154.
    >> Share

  307. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    >> Share

  308. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    >> Share

  309. PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
    Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2021;16:e0256140.
    >> Share

  310. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    >> Share

  311. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    >> Share

  312. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    >> Share

  313. RENAUD A, Caristan A, Seguin A, Agard C, et al
    Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
    PLoS One. 2021;16:e0260196.
    >> Share

  314. BOCH K, Drager S, Zillikens D, Hudemann C, et al
    Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
    PLoS One. 2021;16:e0259586.
    >> Share

  315. HSU CY, Chueh YS, Kuo ML, Lee PT, et al
    Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    PLoS One. 2021;16:e0261727.
    >> Share

  316. BLUTHGEN C, Patella M, Euler A, Baessler B, et al
    Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
    PLoS One. 2021;16:e0261401.
    >> Share

  317. COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
    The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
    PLoS One. 2021;16:e0260896.
    >> Share

  318. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    >> Share

  319. MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
    Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
    PLoS One. 2021;16:e0262171.
    >> Share

  320. CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
    Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    PLoS One. 2021;16:e0261983.
    >> Share

  321. MIDTHASSEL TC, Hansen AH
    Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
    PLoS One. 2021;16:e0261471.
    >> Share

  322. CH'NG JH, Moll K, Wyss K, Hammar U, et al
    Enhanced virulence of Plasmodium falciparum in blood of diabetic patients.
    PLoS One. 2021;16:e0249666.
    >> Share

  323. GAUDILLIERE M, Marsot C, Balaire L, Groisne L, et al
    Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes.
    PLoS One. 2021;16:e0251693.
    >> Share

  324. LO CH, Wang YH, Tsai CF, Chan KC, et al
    Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
    PLoS One. 2021;16:e0251918.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016